近日，轻松健康集团IPO获证监会备案，为赴港上市铺平道路。 这家公司乍听陌生，旗下此前业务可能更为人熟悉轻松筹。"家人突然罹患重病，无法承担高额费用，请好心人帮帮 我们……"过去十多年，这样的求助信息频繁刷屏朋友圈，成为无数家庭在绝境中寻求希望的出口。 总部位于北京，公司创始人杨胤曾任职于IDG Inc。2014年她看好移动互联网浪潮的机会，转身入局创业。直至去年， 轻松健康集团选择剥离轻松筹等业务，如今杨胤带着公司终于走到了IPO门前。 从轻松筹到轻松健康 她带队IPO了 杨胤，早年毕业于北京信息工程学院。招股书显示，她曾就职于IBM中国分部，后于2002年加入IDG Inc.(该公司其后 于2017年被IDG Capital Partners收购)，最后出任职位为副总裁。 转折出现在2014年，众筹成为互联网创业风口，她以天使投资人的身份投资了轻松筹。那时她的想法很简单，通过科 技和互联网的力量，汇聚小钱成就梦想。很快，杨胤辞去了IDG职位，以CEO身份加入轻松筹，正式踏上创业之路。 基于微信和移动端的模式，公司初期吸引了一批尝鲜用户，不过多围绕智能硬件、农产品等项目。直到那年底，轻松 筹出现了一个"拯救 ...

来源：市场资讯 （来源：投资界） 上市梦。 近日，轻松健康集团IPO获证监会备案，为赴港上市铺平道路。 这家公司乍听陌生，旗下此前业务可能更为人熟悉——轻松筹。"家人突然罹患重病，无法承担高额费 用，请好心人帮帮我们……"过去十多年，这样的求助信息频繁刷屏朋友圈，成为无数家庭在绝境中寻 求希望的出口。 总部位于北京，公司创始人杨胤曾任职于IDG Inc。2014年她看好移动互联网浪潮的机会，转身入局创 业。直至去年，轻松健康集团选择剥离轻松筹等业务，如今杨胤带着公司终于走到了IPO门前。 从轻松筹到轻松健康 她带队IPO了 杨胤，早年毕业于北京信息工程学院。招股书显示，她曾就职于IBM中国分部，后于2002年加入IDG Inc.(该公司其后于2017年被IDG Capital Partners收购)，最后出任职位为副总裁。 轻松健康创始人、董事长、执行董事兼首席执行官 杨胤 转折出现在2014年，众筹成为互联网创业风口，她以天使投资人的身份投资了轻松筹。那时她的想法很 简单，通过科技和互联网的力量，汇聚小钱成就梦想。很快，杨胤辞去了IDG职位，以CEO身份加入轻 松筹，正式踏上创业之路。 基于微信和移动端的模 ...

近日，轻松健康集团IPO获证监会备案，为赴港上市铺平道路。 这家公司乍听陌生，旗下此前业务可能更为人熟悉——轻松筹。"家人突然罹患重病，无法承担高额费用，请好心人帮帮我们……"过 去十多年，这样的求助信息频繁刷屏朋友圈，成为无数家庭在绝境中寻求希望的出口。 总部位于北京，公司创始人杨胤曾任职于IDG Inc。2014年她看好移动互联网浪潮的机会，转身入局创业。直至去年，轻松健康集团 选择剥离轻松筹等业务，如今杨胤带着公司终于走到了IPO门前。 从轻松筹到轻松健康，她带队IPO了 杨胤，早年毕业于北京信息工程学院。招股书显示，她曾就职于IBM中国分部，后于2002年加入IDG Inc.(该公司其后于2017年被IDG Capital Partners收购)，最后出任职位为副总裁。 轻松健康创始人、董事长、执行董事兼首席执行官 杨胤 转折出现在2014年，众筹成为互联网创业风口，她以天使投资人的身份投资了轻松筹。那时她的想法很简单，通过科技和互联网的力 量，汇聚小钱成就梦想。很快，杨胤辞去了IDG职位，以CEO身份加入轻松筹，正式踏上创业之路。 基于微信和移动端的模式，公司初期吸引了一批尝鲜用户，不过多围绕智能硬 ...

Core Viewpoint - Easy Health Group submitted a listing application to the Hong Kong Stock Exchange on August 31, with CICC and China Merchants Securities International as joint sponsors, after its previous application became invalid on August 20 [1]. Group 1: Company Overview - Easy Health Group was established in 2014 and focuses on providing digital integrated health services and health insurance solutions [2]. - The company plans to spin off its online disease fundraising service and transfer all equity of this service and the Duol Hospital to Zhonglang Group, which is seen as a compliance necessity and a way to alleviate potential listing burdens [3]. Group 2: Financial Performance - For the reporting periods from 2022 to 2024, Easy Health Group reported revenues of approximately 394 million RMB, 490 million RMB, 945 million RMB, and 656 million RMB, with profits (losses) of -9.098 million RMB, 9.7169 million RMB, 0.899 million RMB, and 8.6045 million RMB respectively [3][4]. - The revenue contribution from digital integrated insurance services has decreased over the years, accounting for 81.5%, 66.7%, 34%, 41.6%, and 22.9% of total revenue during the reporting periods [4]. Group 3: User Engagement and Marketing - The gross profit margin of Easy Health Group has been declining, recorded at 82.6%, 79.9%, 38.3%, and 32.5% across the reporting periods, while active user numbers have also decreased from 70.5 million to 22.7 million [5]. - The company has incurred high sales and marketing expenses, which were approximately 65.8 million RMB, 124 million RMB, 159 million RMB, 72.4 million RMB, and 103 million RMB, representing 16.7%, 25.3%, 16.8%, 20.4%, and 15.7% of revenue respectively [7]. Group 4: Regulatory Issues - In 2022, Easy Health Group's subsidiary, Guangdong Easy Insurance Brokerage Co., was fined 1 million RMB for misleading advertising practices related to insurance products [7]. - Recent complaints against Easy Insurance have surfaced on the Black Cat Complaint platform, alleging issues such as unauthorized charges and aggressive marketing tactics [8].

Core Insights - Qingsong Health Group has submitted a prospectus to the Hong Kong Stock Exchange for a main board listing, marking a renewed application after a previous submission lapsed in January 2025 [1] - The company, established in 2014, focuses on providing a one-stop platform for digital integrated health services and health insurance solutions [1] Financial Performance - Qingsong Health's revenue primarily comes from digital integrated health services and digital insurance services, with total revenues for 2022, 2023, 2024, and the first half of 2025 reported as RMB 394 million, RMB 490 million, RMB 945 million, and RMB 656 million respectively [2] - The gross profit for the same periods was approximately RMB 325 million, RMB 391 million, RMB 362 million, and RMB 213 million, with net profits of RMB -9 million, RMB 97 million, RMB 9 million, and RMB 86 million [2] - The company has a revenue compound annual growth rate (CAGR) of 54.95% and a gross margin CAGR of 5.46% [2] Market Position - According to a report by Frost & Sullivan, Qingsong Health ranks tenth in China's digital integrated health services and health insurance market by revenue as of 2024, and seventh in the digital health services market [4][8] - The digital health services market in China is expected to grow significantly, with a projected market size of RMB 859.8 billion by 2028, reflecting a CAGR of over 30% [8] Technology and Innovation - Qingsong Health has developed a proprietary AI technology stack named AIcare, which enhances customer acquisition, fraud prevention, personalized marketing, and operational efficiency [5] - As of June 30, 2025, approximately 43.3% of the company's employees are involved in IT research and development, with 58 registered patents and 39 software copyrights related to its technology capabilities [5] Customer Base and Partnerships - The company has established partnerships with 144 entities, including 58 insurance companies and 86 pharmaceutical partners, with the top five customers accounting for over 65% of revenue [6][7] - As of June 30, 2025, Qingsong Health has 1.7 million registered users and has launched 294 insurance products in collaboration with its partners [6][7] Funding and Ownership - Qingsong Health has raised approximately $126 million across eight funding rounds, with notable investors including IDG Capital, Tencent, and Sunshine Insurance Group [9] - The founder, Yang Yin, transitioned from being an investor to an entrepreneur, holding a 23.93% stake in the company prior to the IPO [9]

Core Viewpoint - Easy Health Group submitted a listing application to the Hong Kong Stock Exchange on August 31, 2023, after its previous application became invalid on August 20, 2023 [1]. Company Overview - Easy Health Group was established in 2014 and focuses on providing digital integrated health services and health insurance solutions [4]. - In June 2024, the group plans to spin off its online disease fundraising service and transfer all equity in this service and its hospital to Zhonglang Group [4]. Financial Performance - The group reported revenues of approximately 394 million RMB, 490 million RMB, 945 million RMB, and 656 million RMB for the years 2022 to 2024 and the first half of 2025, respectively [4]. - The profits (losses) from continuing operations during the same periods were -9.098 million RMB, 9.7169 million RMB, 0.899 million RMB, and 8.6045 million RMB [5]. - The gross profit margin has been declining, recorded at 82.6%, 79.9%, 38.3%, and 32.5% over the reporting periods [6]. User Engagement - Active user numbers have decreased significantly, from 70.5 million to 22.7 million over the reporting periods [6]. - The group acknowledges that its success relies on maintaining and expanding its user base [8]. Marketing and Compliance Issues - The group has incurred high sales and marketing expenses, which were approximately 65.8 million RMB, 124 million RMB, 159 million RMB, 72.4 million RMB, and 103 million RMB, representing 16.7%, 25.3%, 16.8%, 20.4%, and 15.7% of revenue, respectively [8]. - Easy Health Group's subsidiary, Guangdong Easy Insurance Brokerage Co., was fined 1 million RMB in 2022 for misleading marketing practices [8]. - Recent complaints against Easy Insurance have surfaced, alleging issues such as unauthorized charges and aggressive marketing tactics [9].

智通财经APP获悉，据港交所8月31日披露，轻松健康集团向港交所更新招股书，中金公司、招商证券国际 为其联席保荐人。 数字营销(科普服务)。该公司的数字营销(科普服务)于2023年推出，提供便捷、经济且高效的一站式整合数 字营销解决方案，并针对客户的需求量身定制。该公司支持医药公司及慈善基金会提升健康素养，增强治 疗认知度，并履行社会责任。在整个价值链中，该公司作为值得信赖的合作伙伴，通过科普文章及视频， 将客户(主要是医药公司)与其目标用户群体建立联系。于2023年、2024年及截至2025年6月30日止六个月， 该公司分别向五名、21名及25名客户提供了数字营销(科普服务)。此外，该公司分别于2023年及2024年以及 截至2025年6月30日止六个月创作了逾208,100条、576,600条及292,000条科普内容。 数字医学研究辅助。该公司作为CRO透过提供涵盖整个项目生命周期的综合解决方案，包括医学研究、医 生科普、患者科普、临床研究、市场营销和上市后研究，积极支持医药行业的医学研究需求。与流行病 学、临床医学及统计学等各领域的众多专家团队合作。该公司主要从事真实世界研究(RWS)项目设计、临床 ...